Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

The Whole Body Vibration for Sarcopenic Hospitalized Patients Aged 80+ Years

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04637789
Recruitment Status : Completed
First Posted : November 20, 2020
Last Update Posted : September 29, 2021
Sponsor:
Information provided by (Responsible Party):
Yuxiang Liang, West China Hospital

Study Description
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information
Brief Summary:
Resistance training have been recommended for sarcopenic patients. However, the whole body vibration training would further benefit for sarcopenic patients on the basis of resistance training remains unclear. The purpose of this study is to explore the effect of the whole body vibration training on improving the mobility of elderly patients with sarcopenia. The whole body vibration involves different frequencies that can improve muscle strength and keep aged upright, including the legs and core. These kinds of exercises can improve stability and help prevent falls.

Condition or disease Intervention/treatment Phase
Sarcopenia Behavioral: the whole body vibration Behavioral: resistance training Not Applicable

Study Design
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 60 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Participant)
Primary Purpose: Treatment
Official Title: Effectiveness of The Whole Body Vibration for Treating Sarcopenia in Hospitalized Patients Aged 80 Years and Older
Actual Study Start Date : December 17, 2020
Actual Primary Completion Date : September 1, 2021
Actual Study Completion Date : September 27, 2021
Arms and Interventions
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Arm Intervention/treatment
controlled group Behavioral: resistance training
Resistance training is a form of exercise that improves muscular strength and endurance. During a resistance training workout, you move your limbs against resistance provided by your body weight, gravity,bands, weighted bars or dumbbells.
Experimental: experimental group Behavioral: the whole body vibration
most people stand on the platform with knees bent at about a 30-degree angle, while the surface beneath their feet vibrates an astounding 30 times per second.

Behavioral: resistance training
Resistance training is a form of exercise that improves muscular strength and endurance. During a resistance training workout, you move your limbs against resistance provided by your body weight, gravity,bands, weighted bars or dumbbells.


Outcome Measures
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Primary Outcome Measures :
  1. The change of activities of daily living [ Time Frame: 3 Months ]
    Basic activities of daily living (BADL) assessed by Barthel Index


Secondary Outcome Measures :
  1. The change of usual gait speed [ Time Frame: 3 Months ]
  2. The change of handgrip strength [ Time Frame: 3 Months ]
  3. The change of the score of Short Physical Performance Battery [ Time Frame: 3 Months ]
  4. The change of the score of Timed Up and Go test [ Time Frame: 3 Months ]

Eligibility Criteria
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   80 Years to 100 Years   (Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Sarcopenia defined by the Asia Working Group of Sarcopenia (AWGS)
  • Agree to participant this study and sign the informed consent
  • Aged 80 years or over

Exclusion Criteria:

  • Patients who could not follow the training plan due to cognitive impairment, emotional problems or any other reasons;
  • Severe heart and lung diseases;
  • Renal insufficiency;
  • Any type of tumor;
  • Bedridden patients
Contacts and Locations
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04637789


Locations
Layout table for location information
China, Sichuan
West China Hospital，Sichuan University
Chengdu, Sichuan, China, 610064
Sponsors and Collaborators
Yuxiang Liang
Investigators
Layout table for investigator information
Study Director: ming Yang West China Hospital
Study Director: jiaojiao Jiang West China Hospital
More Information
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information
Layout table for additonal information
Responsible Party: Yuxiang Liang, Physiotherapist, West China Hospital
ClinicalTrials.gov Identifier: NCT04637789    
Other Study ID Numbers: 2020（106）
First Posted: November 20, 2020    Key Record Dates
Last Update Posted: September 29, 2021
Last Verified: September 2021

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Sarcopenia
Muscular Atrophy
Neuromuscular Manifestations
Neurologic Manifestations
 Nervous System Diseases
Atrophy
Pathological Conditions, Anatomical